Transfusion of autologous and allogeneic chromium-51 labelled red cells in ponies T M D Gimlette MD FRCP Department of Nuclear Medicine, The Liverpool Clinic, Myrtle Street, Liverpool This paper describes in detail the results of transfusing autologous and allogeneic cells in ponies.
Methods
The animals used were ponies of mixed breeding, believed to be unrelated; none had previously been transfused and none of the females had foaled. Blood was taken in acid-citrate-dextrose solution and the red cells labelled with chromium-51 (Dacie & Lewis 1975) . Both the autologous and allogeneic cells were kept overnight at about 4°C before labelling, and were treated in the same way. 4-10 ml of resuspended labelled cells were injected into one external jugular vein and samples were obtained from the contralateral side. The haematocrit of each sample was measured and counts corrected to give the activity in I ml of red cells. The first sample was taken at approximately 15 minutes and subsequent results were expressed as per cent of the 15 minute activity per millilitre of red cells. In some studies external counts were made, at various times after injection, over the heart and spleen and in one animal over the liver, using a collimated scintillation counter.
Results
In Figure I , red-cell activities over about three weeks are shown in a group of animals given autologous labelled red cells; one animal was studied twice (We I and II). There was a decrease of about 20% in the first 24 hours and thereafter a less rapid fall, giving a chromium half-life of about 14 days. The true red-cell life in the horse has been shown by various cohort methods to be about 140days (Cornelius et al. 1960 , Carter et al. 1974 , and our data indicate a chromium elution rate, up to three weeks, of about 4% per day in contrast to somewhat over I%in man. By contrast, the results in the same 4 animals and one other, given allogeneic cells without demonstrable incompatibility on routine cross-matching, are shown by broken lines; 90% or more of the activity was lost withi.n two days ( Figure I )..Minor cell population studies gave similar results, indicating that rapid removal of allogeneic cells, rather than extremely rapid elution of chromium, was occurring. Results from the same group, together with 5 additional animals, all given allogeneic cells without demonstrable incompatibility on routine cross-matching and plotted for 24 hours, are again contrasted with results from one animal given autologous cells (We II) ( Figure 2 ). A rapid fall in activity of 50% or more by 4 hours occurred in all these animals. In 5 animals (open symbols) no naturally-occurring antibodies were demonstrable, whereas in 4 (closed symbols) they were present, but it should be noted t~at there is relatively l i ttl difference between these two groups in the survival of the allogeneic cells. In one animal given autologous cells and another given allogeneic cells, carefully-separated plasma samples were counted, but no difference in mean plasma activity (0.05%/1) was found between them; similar values were found in a normal human study (0.09%/1), again suggesting that gross intravascular removal of Chromium was not taking place from the allogeneic cells.
One animal (We II) given autologous cells showed a fall in activity of about 15% in the first two hours and a further decrease of about 4% in 24 hours ( Figure 2 ). This early fall in activity has also been shown in a number of studies at Newmarket, where it was also demonstrated not to occur in splenectomized animals (S J Catling 1975, personal communication) . We concur with the view that this is due to relatively slow mixing with the large splenic blood pool in the horse. Early fall in activity also occurs in the dog; values in Figure 2 indicate the mean results in 6 dogs given autologous chromium-51 labelled red cells (Ryo et al. 1976) . In contrast, there is little further fall up to 24 hours, and this agrees with other data that chromium elution is relatively slow, as in man. The human values ( Figure 2 ) represent the mean results in 5 patients with normal red-cell survival and showed no early loss and a low elution rate. The findings suggested the possibility that the presence of small amounts of naturallyoccurring antibodies, not always readily demonstrable in vitro, might account for the rapid disappearance of allogeneic cells. We therefore decided to study whether this might be overcome by giving the labelled allogeneic cells in a large volume of blood. Labelled allogeneic cells were injected into one animal in whom weak naturally-occurring antibodies were demonstrated (We) and 2 in whom they were not (Pi and Sg), first in a volume of 10 ml, and a rapid fall in activity was observed (Figure 3 , open symbols). Two days later a further dose of labelled cells from the same donors was given to the same recipients mixed with (We), or following (Pi and Sg), 400 ml of the donors' blood. In one animal (We) there was a fall in activity only moderately more rapid than that with autologous cells up to 21 days; in the other 2 (PI and Sg), survival of the red cells in large volume was appreciably better up to one day, but there was virtually no activity after five days. It should, however, be pointed out that in We, if both the autologous activities and the large volume allogeneic activities are corrected for elution (assuming this to be the same in both), the difference between them would be more marked than appears from the data shown, so that even in large volume the survival of allogeneic cells in this animal was far from normal.
The external counting studies were rather difficult to carry out and may be imprecise, but it was observed that in animals given autologous cells the spleen/heart count ratios were from 4 to 9 at 15-30 minutes and increased several-fold over three weeks (Figure 4 , So and Sh); redcell activity is shown for comparison. With allogeneic cells, initial values were similar but heart values fell rapidly giving a very high spleen/heart ratio (We and Ni), suggesting the action of an antibody. In one animal given allogeneic cells, initial liver counts were 1t x heart and 1/5 spleen counts, and after two days heart counts were very low and liver counts 1/8th spleen counts. A steep, early rise in the spleen/heart ratio following allogeneic blood strongly suggests removal of cells due to antibody activity. In similar studies in cattle with allogeneic cells, and using both external counting and post-mortem measurements, highest activity in spleen and next highest in lung has been observed, and intact red cells in the spleen were not labelled, indicating that 100 RED CELL Figure 4 . External counting results are expressed as spleen/heart ratios in 2 animals given allogeneic red cells and 2 given autologous red cells. Corresponding red-cell activities are also shown the splenic activity was due to destroyed, not sequestrated red cells (McSherry et al. 1966 ).The external counting results with autologous cells in horses are markedly different from those in normal man, even allowing for anatomical and counting geometry differences. In normal man initial heart and spleen counts are similar, with a modest fall in heart counts to give a spleen/heart ratio less than 2 after 2-3 weeks.
Discussion
Findings in the horse are different from those in man in several respects. First, with autologous cells there is an early mixing effect, and this produces some difficulty in the accurate estimation of red-cell volume. Second, there is evidence of considerable elution, about 4% a day. Similar rates of fall of activity from chromium-labelled autologous cells were observed in splenectomized and intact horses (S J Catling, 1975, personal communication) , but the increasing spleen/heart ratios that we have observed in intact animals given autologous cells suggest that though there may be some temporary residence of chromium in the spleen, it is not the major site or cause of the elution. Reported studies with chromium-labelled cells have suggested similar high elution in cattle, sheep, goats, cats and rats, but dogs and pigs appear to have elution rates similar to man (Berlin et at. 1959 , Glomski et at. 1971 . The differences are probably related to haemoglobin structure. Rapid in vivo elution and urinary excretion of chromium, and also rapid chromium elution from incubated cells in vitro, have been shown in sheep (Giles et at. 1975) . With similar techniques we have confirmed an elution rate from horse red cells in vitro about five times that in human red cells, but we have carried out no urinary studies.
When allogeneic red cells in small volume were transfused between animals without demonstrable incompatibility on cross matching, there has consistently been rapid removal of the cells, slightly more so when naturally-occurring antibodies could be demonstrated by special tests, and increased splenic uptake of chromium-51. When large volumes are transfused cell survival is appreciably, but variably, improved. Similar findings were recorded with allogeneic cells in cattle, but equally rapid removal of the cells was observed whether the transfusate was a large or small volume (McSherry et at. 1966) . Rapid loss of activity with relatively large allogeneic transfusate volumes has been confirmed by other workers in cattle, and it has also been shown that the fall in activity of chromium-labelled and iron cohort labelled allogeneic red cells was similar (Schnappauf et at. 1965 , Kallfelz & Whitlock 1973 , confirming that rapid removal of cells occurs rather than very rapid elution of chromium.
These findings present a problem in the study of transfusions in the horse, particularly with regard to the survival of red cells transfused in small volume, such as has been assumed to occur as FMH in HDNF. Even where transfusions are given for blood loss, the therapeutic value may be more in the replacement of blood volume than in oxygen carrying capacity.
Addendum: Since submitting this paper for publication, we have repeated allogeneic transfusions in small and large volumes from two of the same donors to the same recipients after intervals of 5 and 15 months and found the survivals of transfused cells were very similar to those after the first transfusions.
Principal red-cell antigens responsible for haemolytic disease of the newborn foal: naturally-occurring antibodies in Thoroughbreds
The development of knowledge of horse blood groups is significant in relation to studies of haemolytic disease of the newborn foal (HDNF). The work can be roughly divided into two phases. The first (see Podliachouk 1957 , Adams 1958 followed Landsteiner's work on the ABO system in man; this led to a number of descriptions of'ABO' systems in the horse, but there were never any clear-cut reciprocal arrangements of antigens and antibodies. This was due to a great extent to the rouleaux formation that is a feature of horse blood: it can be so extensive that it is almost impossible to distinguish from true agglutination and consequently would have led to unreliable results.
The second phase was initiated by the discovery that HDNF was caused by isosensitization of the mother as in the analogous condition in man (Bruner et al. 1948 , Caroli & Bessis 1947 , Coombs et al. 1948 . Workers in several countries then started to investigate blood groups by utilizing antibodies obtained from alloimmunization. Most workers have since been concentrating on these studies for monitoring pedigree registration by carrying out parentage tests (Scott 1973) .This has meant that the earlier work involving naturally-occurring antibodies has been largely disregarded, since the reactions were often weak and inconclusive. Table I shows the red-cell group systems currently recognized in horses. There are seven loci; three are currently single-factor systems, and the remaining four are controlled by multiple alleles (notably the D system). The systems important in HDNF are A and Q: the antigen causing the most severe form of the disease is Aa. 
The blood-group systems

